Fulcrum Therapeutics to Present at BioCentury’s Future Leaders in the Biotech Industry Conference

March 15, 2018

Cambridge, Mass., March 15, 2018 – Fulcrum Therapeutics, a company focused on discovering and developing small molecule therapies that unlock gene regulation to treat serious genetic diseases, will present at BioCentury’s Future Leaders Conference in New York, NY.

Robert Gould, Ph.D., Fulcrum’s President and Chief Executive Officer, will give a presentation titled “Restoring Balance in Gene Regulation” on March 23 at 2:00 p.m. ET.

About Fulcrum Therapeutics

Fulcrum Therapeutics is a biotechnology company developing new medicines to deliver a new future to patients and their families by transforming gene regulation in disease. Fulcrum’s therapies are based on modulating gene regulation via control of genetic on and off switches of disease genes. Fulcrum, headquartered in Cambridge, Mass., was launched by Third Rock Ventures in 2016 and named a “Fierce 15” company later that year. For more information, please visit www.fulcrumtx.com.


Sarah Sutton
Ten Bridge Communications
[email protected]